Ekstrè plant

Ekstrè plant yo refere a pwodwi plant ak ti molekil byolojik ak makromolekil kòm kò prensipal ki fòme nan bi pou yo separe ak pirifye youn oswa plis engredyan aktif nan matyè premyè plant pa mwayen fizik, chimi ak byoloji.

Ekstrè plant tankou ekstrè grenn rezen, ekstrè jape magnolia, ekstrè tomat, ekstrè Citrus aurantium, ekstrè Cherry, ekstrè aloès Vera, ekstrè ginkgo biloba, ekstrè pwa kafe vèt, ekstrè eucommia ulmoides ak lòt ekstrè plant yo te lajman itilize. Li se itilize nan pwodiksyon an nan botanik, aditif manje, manje fonksyonèl, pwodwi chimik chak jou, pestisid botanik ak dwòg veterinè.

Plant extract products have been warmly respected around the world, showing a strong growth momentum. According to customs data, in 2002, the export value of my country's plant extract industry was only 200 million US dollars. By 2011, it had exceeded 1 billion US dollars and reached 1.130 billion US dollars. In 2014, the export value of my country's plant extracts (Shanghe Biological) jumped to 1.778 billion U.S. dollars, an increase of 25.88 percent year-on-year, and the development speed is fast. In the first half of 2015, my country's export of plant extract products was US1.09 billion, accounting for 56.38 percent of my country's total export of Chinese medicine. Shanghe Biology-Plant Extract-Magnolia Bark Extract at the "2015 CNIC China International Forum on Plant Extracts (Beijing) Small Seminar", Yu Zhibin, Secretary-General of the Plant Extract Branch of the China Chamber of Commerce for Import and Export of Medicines and Health Products, said in 2015. In half a year, my country's export of plant extracts to the United States ranked first, accounting for 19 percent of total exports; second was exports to Japan, accounting for 10 percent of exports; and third was exports to Indonesia and Malaysia, each accounting for total exports. Of 9 percent .

Statistics from the China Chamber of Commerce for Import and Export of Medicines and Health Products show that in 2014, my country's export of plant extracts was US1.778 billion, accounting for 49.48 percent of my country's exports of traditional Chinese medicine products, a year-on-year increase of 25.88 percent . "In recent years, extracts have accounted for an increasing proportion of my country's traditional Chinese medicine exports, far higher than the export growth rate of my country's medicines and health products and traditional Chinese medicine products, and has become the most rapidly developing new and expensive industry in the export of Chinese medicine products." Yu Zhibin said.

Li konprann ke dis nan tèt yo se: ekstrè stevia, ekstrè bilberry, lwil ekaliptis, pigman pigman, lwil kannèl, ekstrè reglis, ekstrè marigold, ekstrè Luo Han Guo, ekstrè pikan lèt ak wozo Ding, nan ki sèlman ekstrè stevia ekspòtasyon plis pase 100 milyon dola ameriken.

Fòs veteran nan Etazini kontinye ap dirije mache a. Sèjousi, pran sipleman dyetetik se abitid lavi pifò Ameriken yo, ki se tou yon rezon enpòtan poukisa demann lan pou ekstrè plant nan peyi Etazini te wo. Pou egzanp, Etazini enpòte yon gwo kantite Ginkgo biloba ak ekstrè te vèt soti nan peyi mwen an.

Japan, closely behind the United States, has consistently ranked second for ten consecutive years. It is reported that in the first half of 2015, my country's export of plant extracts (Shanghe Biological) to Japan reached 109 million US dollars, accounting for 10 percent . Indonesia and Malaysia, tied for third place, are both rising stars in the past two years, and they mainly love Chinese essential oil extracts. Yu Zhibin revealed that Indonesia's imports of plant extracts increased by 80.57 percent in 2014, and Malaysia's increased by more than 40 percent .